Literature DB >> 7247450

[Correlation of growth hormone and aetiology of psoriasis].

G Weber, M Neidhardt, A Schmidt, A Geiger.   

Abstract

Pathological alterations of capillaries, accelerated epidermopoesis, increased rate and extent of metabolism in the psoriatic lesion and first manifestation of psoriasis rarely in the first 20 years of life made us decide to investigate the human growth hormone (STH) in blood serum. In 70 patients suffering from psoriasis we found that the extention of skin lesions was correlated to the STH levels, which were determined every 2 h all over the day. The average STH level in psoriasis was three times as high as average value in the group of 40 controls. Thus, one can conclude that psoriasis is caused by a persistence of STH with individual penetrance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247450     DOI: 10.1007/bf00408223

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  10 in total

1.  KINETICS OF HYPERPLASIA IN PSORIASIS.

Authors:  E J VANSCOTT; T M EKEL
Journal:  Arch Dermatol       Date:  1963-10

2.  Biochemical and physiological clues to the nature of psoriasis.

Authors:  W B SHELLEY; R P ARTHUR
Journal:  AMA Arch Derm       Date:  1958-07

3.  [The problem of heredity of soriasis].

Authors:  K HOEDE
Journal:  Hautarzt       Date:  1957-10       Impact factor: 0.751

4.  Psoriasis in twins.

Authors:  A S HARO
Journal:  Ann Med Intern Fenn       Date:  1955

5.  [Psoriasis. A questionnaire study of 536 patients].

Authors:  O Braun-Falco; G Burg; E M Farber
Journal:  Munch Med Wochenschr       Date:  1972-06-09

6.  [Behavior of psoriasis during pregnancy].

Authors:  H Flegel; D Kluger
Journal:  Z Haut Geschlechtskr       Date:  1968-12-15

7.  [Characteristics of psoriasis in childhood].

Authors:  N Sönnichsen; V Grosser; M Lübke
Journal:  Dermatol Monatsschr       Date:  1979-08

8.  [Enzymatic mechanisms in psoriasis vulgaris].

Authors:  G Weber
Journal:  Arch Klin Exp Dermatol       Date:  1966

Review 9.  [Dehydroepiandrosterone deficiency in psoriasis. Hypothesis on the etiopathogenesis of this disease].

Authors:  H Holzmann; P Benes; B Morsches
Journal:  Hautarzt       Date:  1980-02       Impact factor: 0.751

10.  [Relationship between psoriasis and human growth hormone (author's transl)].

Authors:  G Weber; M Neidhardt
Journal:  MMW Munch Med Wochenschr       Date:  1980-11-21
  10 in total
  9 in total

1.  Somatostatin treatment of psoriasis.

Authors:  J J Guilhou; A Boulanger; G Barneon; P Vic; J Meynadier; J C Tardieu; J Clot
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

2.  Growth hormone levels in psoriasis.

Authors:  G Weber; H Frey; M Neidhardt
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

3.  Growth hormone producing hyperplasia of pituitary gland in psoriasis.

Authors:  G Weber; G Pliess; U Heitz
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Bromocriptine treatment of psoriasis.

Authors:  J J Guilhou; E Guilhou
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  Treatment of psoriasis with bromocriptin.

Authors:  G Weber; M Neidhardt; H Frey; K Galle; A Geiger
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

6.  Psoriasis and human growth hormone: aetiology and therapy.

Authors:  G Weber; G Klughardt; M Neidhardt
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

7.  Growth hormone promotes lymphangiogenesis.

Authors:  Nadja Erika Banziger-Tobler; Cornelia Halin; Kentaro Kajiya; Michael Detmar
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

8.  Treatment of psoriasis with somatostatin.

Authors:  G Weber; G Klughardt; M Neidhardt; K Galle; H Frey; A Geiger
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

9.  Growth hormone levels in psoriasis.

Authors:  G C Priestley; D J Gawkrodger; J Seth; S M Going; J A Hunter
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.